Abstract:The detection of tumor markers plays an important role in the screening, early diagnosis and treatment of high-risk cancer patients. Prostatic cancer is one of the most common malignancies of the male genitourinary system, and has an increasing trend in recent years. Its morbidity is generally influenced by region and ethnicity. The common clinical markers of prostate cancer include prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA), alpha-fonny 1 kievase A mesozyme (AMACR, P504S), prostate-acid phosphatase (PAP), and calcium phosphatidyl binding protein 3 (ANXA3). Most of these markers are composed of proteins or enzymes, which are produced by normal or cancerous prostate cells. Of these, prostate-specific antigen (PSA) and prostate-acid phosphatase (PAP) are considered to be the most meaningful markers of the prostatic cancer. Detection of PSA is widely used in the early detection and monitoring of prostate cancer patients, while analysis of PAP is often used to detect advanced prostate cancer metastases and evaluate the therapeutic effect. Therefore, the analysis of PSA and PAP in the human serum is of great significance for the monitoring of disease status in clinical diagnosis and treatment. In this review the recent advances in the methodological study for detection of prostate cancer markers are reviewed along with the description of their structures and biological functions. The detection technologies of prostate-specific antigen and prostate acid phosphatase are emphatically introduced, which mainly contain colorimetric techniques, electrochemical methods, fluorescence methods and surface resonance plasmon techniques. On the basis of summarizing the research progress in this field in recent decades, the future development of prostate cancer marker analysis is prospected. This review is expected to provide a useful guidance for the study of prostate cancer markers.

Actuality and developmental trends of clinical detection technology of tumor marker

Application and advances of detection technology for tumor markers

Research advances in nicotinamide N-methyltransferase as a potential tumor biomarker

Tumor biomarkers for diagnosis, prognosis and targeted therapy

[Current Status and Latest Advancement in Developing Techniques for Tumor Early Detection].

The Application of Bio-Nanotechnology in Tumor Diagnosis and Treatment: A View

Serum molecular tumor markers:from mining to clinical application

Colorimetric Immunoassay for Detection of Tumor Markers

Biomedical and Clinical Applications of Immunoassays and Immunosensors for Tumor Markers

Current research status of tumor cell biomarker detection

Electrochemical Analysis of Tumor Marker Proteins

Research Progress of CDT.

Medical imaging in tumor precision medicine: opportunities and challenges

Advanced Devices for Tumor Diagnosis and Therapy

Circulating tumor DNA analysis for tumor diagnosis

Research Progress of Targeted Nanomaterials on Cancer Diagnose and Therapy

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques

The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer

Advances In Analytical Methodology Of Prostate Cancer Markers

Personalized Precision Diagnosis and Therapy：Development and Challenge in Clinic (II)

Personalized Precision Diagnosis and Therapy：Development and Challenge in Clinic